Free tool
FAERS Monitor: Strattera
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021411 or its brand name (Strattera, Atomoxetine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
23,874
Serious
9,462
40% of reports
Hospitalization
3,460
Death reported
1,574
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective2,439
- fatigue1,931
- nausea1,898
- vomiting1,522
- headache1,510
- dizziness1,430
- somnolence1,361
- off label use1,304
- insomnia1,281
- depression1,198
- feeling abnormal1,186
- abdominal pain upper1,181
- prescribed overdose1,145
- anxiety1,056
- suicidal ideation1,010
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 5,235 |
| 2005 | 3,700 |
| 2006 | 579 |
| 2007 | 510 |
| 2008 | 415 |
| 2009 | 557 |
| 2010 | 398 |
| 2011 | 414 |
| 2012 | 474 |
| 2013 | 409 |
| 2014 | 534 |
| 2015 | 4,499 |
| 2016 | 808 |
| 2017 | 508 |
| 2018 | 416 |
| 2019 | 441 |
| 2020 | 355 |
| 2021 | 296 |
| 2022 | 366 |
| 2023 | 441 |
| 2024 | 722 |
| 2025 | 1,215 |
| 2026 | 582 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,285 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| prescribed overdoseSignal | 1,145 | 55.3 | 52.2 | 57,485 |
| suicidal ideationSignal | 1,010 | 9.8 | 9.2 | 7,936 |
| somnolenceSignal | 1,361 | 6.0 | 5.7 | 5,667 |
| abdominal pain upperSignal | 1,181 | 5.1 | 4.8 | 3,878 |
| depressionSignal | 1,198 | 4.7 | 4.4 | 3,457 |
| feeling abnormalSignal | 1,186 | 4.4 | 4.1 | 3,107 |
| insomniaSignal | 1,281 | 4.3 | 4.0 | 3,209 |
| anxietySignal | 1,056 | 3.3 | 3.1 | 1,686 |
| vomitingSignal | 1,522 | 2.9 | 2.7 | 1,872 |
| dizzinessSignal | 1,430 | 2.5 | 2.4 | 1,350 |
| fatigueSignal | 1,931 | 2.2 | 2.1 | 1,289 |
| headacheSignal | 1,510 | 2.1 | 2.0 | 923 |
| nauseaSignal | 1,898 | 2.1 | 2.0 | 1,156 |
| drug ineffective | 2,439 | 1.6 | 1.6 | 634 |
| off label use | 1,304 | 1.3 | 1.2 | 101 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.